GSK recognised as leading global force for change

GlaxoSmithKline (GSK) has been named one of the world’s leading Change agents by Fortune magazine. GSK is ranked 6th in Fortune’s inaugural Change the World List. GSK is also the highest ranked pharmaceutical company on the list.

GSK was lauded by the magazine for its work in developing RTS,S, a candidate Malaria vaccine that was recently granted a positive scientific opinion by the European Medicines Agency (EMA). The World Health Organization is now in the process of formulating a policy recommendation on use of RTS,S in national immunisation programmes once approved by national regulatory authorities.

RTS,S was developed in partnership with the PATH Malaria Vaccine Initiative. RTS,S has been designed to prevent malaria caused by the Plasmodium falciparum parasite, which is most prevalent in sub-Saharan Africa (SSA). In 2013, there were an estimated 584,000 deaths from malaria with around 90 percent of these occurring in SSA, and 83 percent in children under the age of five in SSA.

In its news release Fortune stated “In a time when governments seem ineffectual and society is ever more divided, dozens of big companies are forging ahead to tackle the world's most intransigent problems. For anyone who's ever doubted the power of the profit motive – or thought business can't be an enduring force for good – Fortune has gathered 51 companies who are doing well by doing good in the inaugural "Change the World" list.”

Fortune Editor Alan Murray said that the list is meant to shine a spotlight on companies that have made significant progress in addressing major social problems as part of their core business strategy. He added “Business in pursuit of profit still offers the best hope of addressing many of mankind's most deeply rooted problems. Companies that are making genuine efforts to change the world for the better should be encouraged."

For more details about Fortune’s Change the World list, please visit